SCHEMBL24935348

SCHEMBL24935348

CC(=O)CCc1ccc(C(=O)Nc2ccc(C)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.67
RAB9A P51151 6/20 0.67
CCR5 P51681 3/20 0.66
NR1H4 Q96RI1 2/20 0.58
SMN1; SMN2 Q16637 3/20 0.57
MAPT P10636 3/20 0.57
ENPP1 P22413 1/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
TRPV1 Q8NER1 1/20 0.51
KDM4E B2RXH2 3/20 0.51
NAMPT P43490 2/20 0.51
POLB P06746 1/20 0.51
DUSP3 P51452 1/20 0.51
PTPN5 P54829 1/20 0.51
PTPN11 Q06124 1/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
LMNA P02545 2/20 0.50
ALDH1A1 P00352 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17664553 0.88 NR1H4 (0.74) NPC1RAB9ACCR5NR1H4SMN1; SMN2
SCHEMBL14490981 0.85 CCR5 (0.63) NPC1RAB9ACCR5NR1H4SMN1; SMN2
SCHEMBL8361574 0.84 NPC1 (0.71) NPC1RAB9ACCR5NR1H4SMN1; SMN2
SCHEMBL8868824 0.84 NPC1 (0.71) NPC1RAB9ACCR5NR1H4SMN1; SMN2
SCHEMBL25815514 0.84 NPC1 (0.71) NPC1RAB9ACCR5NR1H4SMN1; SMN2
SCHEMBL24935402 0.84 NPC1 (0.71) NPC1RAB9ACCR5NR1H4SMN1; SMN2
SCHEMBL8867477 0.84 NPC1 (0.71) NPC1RAB9ACCR5NR1H4SMN1; SMN2
SCHEMBL8867481 0.84 NPC1 (0.71) NPC1RAB9ACCR5NR1H4SMN1; SMN2
SCHEMBL28648566 0.83 RAB9A (0.73) NPC1RAB9ACCR5NR1H4SMN1; SMN2
SCHEMBL8363015 0.82 TRPV1 (0.76) NPC1RAB9ACCR5SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4119546-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Suzhou Kintor Pharmaceuticals, Inc. (CN) 2023-01-18 EP disclosed